HER2 Support Group Forums - View Single Post - Positive interim results of ARRY-380 in Phase 1 trial announced

News · 12-13-2009, 09:50 PM

Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 (ErbB2) inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.

More...

12-13-2009, 09:50 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,981	Positive interim results of ARRY-380 in Phase 1 trial announced Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 (ErbB2) inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients. More...